These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8017742)
21. Effect of omeprazole on serum gastrin levels: influence of age and sex. Koop H; Naumann-Koch C; Arnold R Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116 [TBL] [Abstract][Full Text] [Related]
22. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity. Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516 [TBL] [Abstract][Full Text] [Related]
24. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569 [TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists. Koop H; Hotz J; Pommer G; Klein M; Arnold R Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342 [TBL] [Abstract][Full Text] [Related]
26. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group. Festen HP; Schenk E; Tan G; Snel P; Nelis F Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459 [TBL] [Abstract][Full Text] [Related]
27. Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole. Meijer JL; Jansen JB; Biemond I; Kuijpers IJ; Lamers CB Aliment Pharmacol Ther; 1994 Apr; 8(2):221-7. PubMed ID: 8038355 [TBL] [Abstract][Full Text] [Related]
28. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group. Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694 [TBL] [Abstract][Full Text] [Related]
29. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927 [TBL] [Abstract][Full Text] [Related]
30. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus. Nishi T; Makuuchi H; Weinstein WM Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202 [TBL] [Abstract][Full Text] [Related]
31. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777 [TBL] [Abstract][Full Text] [Related]
32. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. McTavish D; Buckley MM; Heel RC Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683 [TBL] [Abstract][Full Text] [Related]
33. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists. Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911 [TBL] [Abstract][Full Text] [Related]
35. Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis. Ohkusa T; Maekawa T; Arakawa T; Nakajima M; Fujimoto K; Hoshino E; Mitachi Y; Hamada S; Mine T; Kawahara Y; Nagai T; Aoyama N; Yoshida N; Tadokoro K; Chida N; Konda Y; Seno H; Shimatani T; Inoue M; Sato N Aliment Pharmacol Ther; 2005 Jun; 21(11):1331-9. PubMed ID: 15932363 [TBL] [Abstract][Full Text] [Related]
36. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Brunner G; Creutzfeldt W; Harke U; Lamberts R Digestion; 1988; 39(2):80-90. PubMed ID: 3410170 [TBL] [Abstract][Full Text] [Related]
37. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis. Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S; Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850 [TBL] [Abstract][Full Text] [Related]
38. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548 [TBL] [Abstract][Full Text] [Related]
39. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695 [TBL] [Abstract][Full Text] [Related]